Feature Channels: Pharmaceuticals

Filters close
Newswise: Case Western Reserve University researchers report rise in global fungal drug-resistant infections
Released: 18-Mar-2024 9:00 AM EDT
Case Western Reserve University researchers report rise in global fungal drug-resistant infections
Case Western Reserve University

A global wave of infections caused by fungi growing drug-resistant has the medical community issuing precautions on how to protect yourself.

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 14-Mar-2024 2:00 PM EDT Released to reporters: 12-Mar-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 14-Mar-2024 11:05 AM EDT Released to reporters: 14-Mar-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 11:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 13-Mar-2024 3:05 PM EDT
Radyus Research Forges Strategic Partnership with Southern Research to Propel Life Sciences Commercialization
Radyus Research

Radyus Research partners with Southern Research for an innovative alliance in the development of new drugs.

   
Newswise: Cows to the rescue for diabetics? Transgenic cow produces human insulin in milk
Released: 13-Mar-2024 11:05 AM EDT
Cows to the rescue for diabetics? Transgenic cow produces human insulin in milk
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

An unassuming brown bovine from the south of Brazil has made history as the first transgenic cow capable of producing human insulin in her milk.

Newswise: What Makes a Pathogen Antibiotic-Resistant?
Released: 7-Mar-2024 9:00 AM EST
What Makes a Pathogen Antibiotic-Resistant?
Sanford Burnham Prebys

In a new study, Sanford Burnham Prebys researchers, led by Andrei L. Osterman, Ph.D., combined experimental evolution in a continuous culturing device with whole genome sequencing of evolving cultures to track how two bacterial pathogens acquired drug resistance against a pair of antibiotics, one long-used and the other experimental.

Newswise: Simmons Cancer Center awarded nearly $19 million in CPRIT funding
Released: 4-Mar-2024 11:05 AM EST
Simmons Cancer Center awarded nearly $19 million in CPRIT funding
UT Southwestern Medical Center

Nine scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $13 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research and prevention efforts on a wide range of cancer issues. UTSW received another $6 million for recruitment efforts.

Released: 4-Mar-2024 8:05 AM EST
HIV Medication Can be Used Safely with Gender-Affirming Hormone Therapy
Thomas Jefferson University

New research shows HIV medications can be taken at the same time as hormone treatment without losing potency of either therapy.

Released: 29-Feb-2024 2:05 PM EST
Q&A: How a potential treatment for Alzheimer’s disease could also work for Type 2 diabetes
University of Washington

Alzheimer’s disease and Type 2 diabetes are part of a family of amyloid diseases that are characterized by having proteins that cluster together. University of Washington researchers have demonstrated more similarities between the two diseases.

Released: 28-Feb-2024 9:05 PM EST
In fight against brain pathogens, the eyes have it
Yale University

The eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found.

Released: 28-Feb-2024 3:05 PM EST
How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis
University of North Carolina School of Medicine

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

Newswise: Light stimulates a new twist for synthetic chemistry
27-Feb-2024 12:05 AM EST
Light stimulates a new twist for synthetic chemistry
Hokkaido University

Molecules that are induced by light to rotate bulky groups around central bonds could be developed into photo-activated bioactive systems, molecular switches, and more.

Released: 27-Feb-2024 8:05 PM EST
Five Cutting-edge Advances in Biomedical Engineering and Their Applications in Medicine
University of California San Diego

Bridging precision engineering and precision medicine to create personalized physiology avatars. Pursuing on-demand tissue and organ engineering for human health. Revolutionizing neuroscience by using AI to engineer advanced brain interface systems. Engineering the immune system for health and wellness. Designing and engineering genomes for organism repurposing and genomic perturbations.

Newswise: How gut bacteria become ‘persisters’ to avoid antibiotics
Released: 27-Feb-2024 1:05 PM EST
How gut bacteria become ‘persisters’ to avoid antibiotics
UT Southwestern Medical Center

A subpopulation of gut bacteria given a commonly used antibiotic became "persisters" that were able to survive without developing true resistance, UT Southwestern Medical Center scientists discovered. Their findings, published in Cell Host & Microbe, could lead to better ways to fight bacterial infections.

Newswise: ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Released: 27-Feb-2024 9:00 AM EST
ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Digital Science and Research Solutions Ltd

Digital Science is pleased to announce that ReadCube, an award-winning leader in literature management and full-text document delivery, has launched a new solution for research-driven organizations – known simply as Literature Review by ReadCube.

Replaces 807569

       
Newswise: ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Released: 27-Feb-2024 9:00 AM EST
ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Digital Science and Research Solutions Ltd

Digital Science is pleased to announce that ReadCube, an award-winning leader in literature management and full-text document delivery, has launched a new solution for research-driven organizations – known simply as Literature Review by ReadCube.

       
Newswise: RUDN doctors scanned medications through the packaging and inside the body
Released: 27-Feb-2024 4:05 AM EST
RUDN doctors scanned medications through the packaging and inside the body
Scientific Project Lomonosov

RUDN University doctors demonstrated the capabilities of a new method for remote analysis of drugs in packaging and after entering the body. They can be assessed using radio thermal emission of nanoparticles in drugs. Scientists were able to check the suitability of the medicine without opening the packaging or monitor it inside the body.

Newswise: Poison center calls for ‘magic mushrooms’ spiked after decriminalization, study finds
Released: 26-Feb-2024 9:05 PM EST
Poison center calls for ‘magic mushrooms’ spiked after decriminalization, study finds
University of Virginia Health System

Calls to U.S. poison centers involving psilocybin, or “magic mushrooms,” among adolescents and young adults rose sharply after several U.S. cities and states began decriminalizing the hallucinogen, University of Virginia School of Medicine researchers have found.

Newswise: Notre Dame develops user-friendly platform to access comprehensive nationwide opioid database
Released: 26-Feb-2024 1:05 PM EST
Notre Dame develops user-friendly platform to access comprehensive nationwide opioid database
University of Notre Dame

To provide a clear picture of opioid manufacture and travel, the University of Notre Dame developed a user-friendly interface to enable public access to more than 10 years of national controlled substance transaction information. This platform makes querying easier and faster, providing transactional data on 14 different opioids including fentanyl, hydrocodone and oxycodone.

   
Released: 22-Feb-2024 11:05 AM EST
Antidiabetic drugs could lower risk of primary and secondary brain cancer
University of Bristol

Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 11:00 AM EST
Mark Cuban Drug Company may offer savings for urology drugs
Wolters Kluwer Health: Lippincott

An online pharmacy offering standardized, transparent pricing can reduce out-of-pocket costs for patients taking common medications prescribed by urologists, suggests a study in the March issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: RUDN doctors named the most allergen-inducing drugs
Released: 21-Feb-2024 9:20 AM EST
RUDN doctors named the most allergen-inducing drugs
Scientific Project Lomonosov

RUDN University doctors collected statistics on cases of extreme drug allergies - anaphylaxis. The authors presented the results in different age groups and named the most dangerous drugs for an allergic reaction.

Newswise: RUDN pharmacists proposed ways to increase the activity of levofloxacin and overcome bacterial resistance to antimicrobial agents
Released: 21-Feb-2024 9:15 AM EST
RUDN pharmacists proposed ways to increase the activity of levofloxacin and overcome bacterial resistance to antimicrobial agents
Scientific Project Lomonosov

RUDN University pharmacists modeled derivative molecules of the antibacterial levofloxacin to find out what biological functions its individual structural fragments - pharmacophores - are responsible for. This is necessary to increase the effectiveness of the drug, as bacteria become increasingly resistant to antibiotics.

16-Feb-2024 8:00 AM EST
Compounds in female ginseng could lead to new osteoporosis treatments
American Chemical Society (ACS)

Drugs for treating osteoporosis can be expensive and have side effects. In the search for alternative drug candidates, researchers reporting in ACS Central Science have discovered and fully replicated a compound from female ginseng that had potent anti-osteoporotic activity in cellular tests.

   
Released: 15-Feb-2024 5:05 PM EST
UCLA-led research results in FDA approval of 4-drug combination for frontline treatment of metastatic pancreatic cancer
University of California, Los Angeles (UCLA), Health Sciences

A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil has been approved by the FDA for the first-line treatment of metastatic pancreatic adenocarcinoma.

Released: 15-Feb-2024 2:00 PM EST
UIC research helps create new antibiotic that evades bacterial resistance
University of Illinois Chicago

New drug inspired by images that captured how bacteria block antibiotic activity

   
Newswise: Praedicare Leverages AI, Mathematical Models of Disease Progression and Mapping in World’s First In Silico Clinical Trial of Its Kind
Released: 15-Feb-2024 10:00 AM EST
Praedicare Leverages AI, Mathematical Models of Disease Progression and Mapping in World’s First In Silico Clinical Trial of Its Kind
Praedicare

The in silico trial demonstrated 2X the efficacy of the current treatment (>80% vs 39%); 3X shorter treatment time to cure (6 vs 18 months); 1 drug compared to a 3-drug combo for the standard of care; and preclinical results in shorter time than animal models.

Released: 14-Feb-2024 4:05 AM EST
Can Olive Oil Reverse Genetic Predisposition for Alzheimer’s?
Alzheimer's Center at Temple University Lewis Katz School of Medicine

Clinical studies suggest the Mediterranean diet, and one of its main components, extra virgin olive oil (EVOO), improves cognitive function and slows Alzheimer's disease (AD) progression. Researchers will now investigate whether this is true even for people with a family history of AD and signs of genetic predisposition caused by dysfunction in the APOE gene.

Released: 13-Feb-2024 10:30 AM EST
SLU Professor Shows Ethical Duality of Using Prescription Drug Monitoring Programs in Fight Against Opioids
Saint Louis University Medical Center

Saint Louis University’s Liz Chiarello, Ph.D., associate professor of sociology recently published an article in the American Sociological Review, the flagship journal of the American Sociological Association. The article explores pharmacists’ use of prescription drug monitoring programs (PDMPs) and the ethical and practical application of PDMPs in healthcare.

Newswise: Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice
Released: 13-Feb-2024 8:30 AM EST
Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice
Florida Atlantic University

Sandalwood oil has been used worldwide for centuries. Now, a study is the first to demonstrate in vivo the chemo-preventive properties of a by-product of the oil in a mouse model. Results show administering alpha-santalol reduced visible prostate tumors, protected the normal tissue, and delayed progression from a precancerous condition to a high-grade form of cancer. These findings are significant because mortality in prostate cancer patients is mainly attributable to advanced stages of the disease.

Released: 12-Feb-2024 11:05 AM EST
Antibody drug conjugates make strides in ovarian cancer with recent FDA approval
University of California, Los Angeles (UCLA), Health Sciences

The UCLA team played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate (ADC), mirvetuximab soravtansine, for the treatment of platinum-resistant ovarian cancer.

Released: 7-Feb-2024 5:00 PM EST
MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy
University of Texas MD Anderson Cancer Center

MD Anderso and C-Biomex today announced a strategic collaboration to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.

Newswise: Covid vaccine for pregnant women safe for newborn infants
Released: 7-Feb-2024 1:05 AM EST
Covid vaccine for pregnant women safe for newborn infants
Karolinska Institute

No increased risks for babies, and for some serious neonatal complications lower risks.

Released: 5-Feb-2024 2:05 PM EST
Methadone Use in Early Pregnancy May Lead to More Birth Defects Than Buprenorphine
Rutgers University-New Brunswick

Analysis from Rutgers Health and Harvard links first-trimester methadone use with a greater risk of various birth defects than buprenorphine use.

Released: 1-Feb-2024 10:05 PM EST
Gut bacteria can process dietary fiber into an anti-allergy weapon, finds new study
Tokyo University of Science

The intricate relationship that exists between humans and the gut microbiome has become a hot research topic, and scientists are constantly uncovering new reasons why a healthy diet can lead to a healthier life.

Newswise:Video Embedded live-event-nurses-the-most-trusted-profession-in-an-age-of-mistrust
VIDEO
Released: 1-Feb-2024 5:00 PM EST
VIDEO AND TRANSCRIPT: Nurses -- The Most Trusted Profession in an Age of Mistrust
Newswise

For 21 years, nurses have consistently been the most trusted profession, according to the yearly Gallup poll. (The new poll will be issued by the end of January). Dr Rushton, who specializes in burnout, will speak on trust, moral injury, and how nurses cope in this day and age.

Released: 1-Feb-2024 12:05 PM EST
American Society of Anesthesiologists welcomes improvements to No Surprises Act IDR process
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) commends the Centers for Medicare & Medicaid Services (CMS) for taking positive steps towards returning balance to the independent dispute resolution (IDR) process of the No Surprises Act (NSA) through a recently proposed rule.

Released: 31-Jan-2024 5:05 PM EST
Molecule can quickly, and briefly, boost white blood cell counts
Yale University

Treatment with a molecule known as A485 can quickly and temporarily increase levels of white blood cells, a critical part of the body’s immune system, an effect that is difficult to deliver with currently available pharmaceuticals, a new Yale study finds.

Newswise: Engineering viruses to kill deadly pathogens
Released: 31-Jan-2024 12:05 PM EST
Engineering viruses to kill deadly pathogens
Northwestern University

Northwestern University researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out.

Released: 30-Jan-2024 1:05 PM EST
DNA particles that mimic viruses hold promise as vaccines
Massachusetts Institute of Technology (MIT)

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.



close
2.30313